Abstract
Improving the situation for the growing number of CHF patients is a major and growing public health issue. It has been estimated that approximately 2 million Americans suffer from CHF (1). This number is likely to increase over the next decades with the improvement of the average life expectancy since the prevalence of CHF is highly associated with increased age. Moreover, advances in the medical treatment of arterial hypertension and myocardial infarction and the surgical treatment of multivessel coronary artery disease and congenital and valvular heart disease have life-saving potential. Many of these patients will ultimately develop CHF, a common endstage of most cardiovascular conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Furberg CD, Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol 1985;55:1110–1113.
Franciosa JA, Wilen M, Ziesche S, Cohn J. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831–836.
Furberg CD, Yusuf S. Effect of drug therapy on survival in chronic heart failure. Adv Cardiol 1986;34:124–130.
Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314:1547–1552.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Furberg, C. (1987). What CHF Trials have Shown to Date and What is Needed?. In: Morganroth, J., Moore, E.N. (eds) Congestive Heart Failure. Developments in Cardiovascular Medicine, vol 75. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2077-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2077-7_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9232-6
Online ISBN: 978-1-4613-2077-7
eBook Packages: Springer Book Archive